Back
46
63
52
Day Range
$13.80
$14.21
52-Week Range
$10.80
$79.18
Volume
948,188
50D / 200D Avg
$25.57
/
$49.00
Prev Close
$14.07
Price History
Financial Trends
Peer Comparison
vs Technology sector median (621 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 7.1 | 12.3 |
| P/B | 2.0 | 2.9 |
| ROE % | 32.6 | 8.9 |
| Net Margin % | 13.7 | 5.6 |
| Rev Growth 5Y % | 38.1 | 9.2 |
| D/E | 0.1 | 0.3 |
Analyst Price Target
Hold
$35.83
+159.3%
Low: $18.00
High: $70.00
Forward P/E
18.8
Forward EPS
$0.75
EPS Growth (est.)
+0.0%
Est. Revenue
680 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$1.50
$1.21 – $1.87
|
970 M | 1 |
| FY2029 |
$1.25
$1.01 – $1.56
|
890 M | 1 |
| FY2028 |
$1.96
$1.09 – $2.96
|
940 M | 3 |
Insider Trading Activity
14 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 23, 2025 |
Freyre Michelle
Director
|
other | 6,918 | — | — |
| May 23, 2025 |
Freyre Michelle
Director
|
sell | 1,730 | $74.60 | $129,058 |
| May 23, 2025 |
Whitehurst James M
Director
|
other | 6,918 | — | — |
| May 23, 2025 |
Whitehurst James M
Director
|
sell | 1,730 | $74.60 | $129,058 |
| May 22, 2025 |
Freyre Michelle
Director
|
grant | 2,410 | — | — |
| May 22, 2025 |
Whitehurst James M
Director
|
grant | 2,410 | — | — |
| May 22, 2025 |
Harford Barney
Director
|
grant | 2,410 | — | — |
| May 22, 2025 |
Friend Matthew
Director
|
grant | 2,410 | — | — |
| May 22, 2025 |
HOOPER MICHELE J
Director
|
grant | 2,410 | — | — |
| May 22, 2025 |
ISAACSON WALTER
Director
|
grant | 2,410 | — | — |
| May 22, 2025 |
PHILIP EDWARD M
Director
|
grant | 5,422 | — | — |
| May 22, 2025 |
BREWER ROSALIND G
Director
|
grant | 2,410 | — | — |
| May 22, 2025 |
Ward Laysha
Director
|
grant | 2,410 | — | — |
| May 22, 2025 |
SHAPIRO EDWARD
Director
|
grant | 2,410 | — | — |
Key Takeaways
Revenue grew 38.12% annually over 5 years — strong growth
ROE of 32.63% indicates high profitability
Debt/Equity of 0.10 — conservative balance sheet
Generating 83.65M in free cash flow
P/E of 7.10 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 12.96%
Growth
Revenue Growth (5Y)
38.12%
Revenue (1Y)25.16%
Earnings (1Y)9.12%
FCF Growth (3Y)1.10%
Quality
Return on Equity
32.63%
ROIC20.36%
Net Margin13.67%
Op. Margin14.67%
Safety
Debt / Equity
0.10
Current Ratio5.24
Interest Coverage0.00
Valuation
P/E Ratio
7.10
P/B Ratio1.98
EV/EBITDA3.58
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 25.16% | Revenue Growth (3Y) | 26.18% |
| Earnings Growth (1Y) | 9.12% | Earnings Growth (3Y) | 37.55% |
| Revenue Growth (5Y) | 38.12% | Earnings Growth (5Y) | 67.95% |
| Profitability | |||
| Revenue (TTM) | 809.84M | Net Income (TTM) | 110.75M |
| ROE | 32.63% | ROA | 9.73% |
| Gross Margin | 72.69% | Operating Margin | 14.67% |
| Net Margin | 13.67% | Free Cash Flow (TTM) | 83.65M |
| ROIC | 20.36% | FCF Growth (3Y) | 1.10% |
| Safety | |||
| Debt / Equity | 0.10 | Current Ratio | 5.24 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 7.10 | P/B Ratio | 1.98 |
| P/S Ratio | 0.97 | PEG Ratio | 2.16 |
| EV/EBITDA | 3.58 | Dividend Yield | 0.00% |
| Market Cap | 786.62M | Enterprise Value | 425.34M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 809.84M | 647.04M | 508.69M | 324.52M | 222.56M |
| Net Income | 110.75M | 101.49M | 58.53M | 21.73M | 13.92M |
| EPS (Diluted) | 1.80 | 1.66 | 1.00 | 0.11 | 0.08 |
| Gross Profit | 588.71M | 468.32M | 358.23M | 218.05M | 153.18M |
| Operating Income | 118.77M | 115.60M | 74.32M | 27.67M | 19.51M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.14B | 438.88M | 404.91M | 216.41M | 142.97M |
| Total Liabilities | 741.30M | 156.58M | 121.80M | 117.70M | 74.32M |
| Shareholders' Equity | 396.50M | 282.30M | 283.11M | 98.71M | 68.65M |
| Total Debt | 40.93M | 22.71M | 12.51M | 15.88M | 5.35M |
| Cash & Equivalents | 402.21M | 50.34M | 36.54M | 40.96M | 28.83M |
| Current Assets | 601.80M | 223.37M | 223.81M | 145.93M | 92.70M |
| Current Liabilities | 114.83M | 124.80M | 109.31M | 90.41M | 55.57M |
Strategy Scores
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
#211 of 618
#77 of 670
#43 of 203
Recent Activity
Entered
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026
Entered
Value Investing (Warren Buffett)
Mar 24, 2026